Courtesy of Revvity

Revvity launches EONIS Q system enabling faster, simplified newborn screening for SMA and SCID

Nov. 27, 2023
Molecular diagnostics workflow reduces complexity and costs for labs looking to expand newborn screening capabilities.
288372549 © Abdul Moizjaangda, 28929477 © Stylettt |
Dreamstime Xl 288372549
Photo 18803340 © Bjorn Hovdal |
Dreamstime Xxl 18803340
Photo 89801171 © Rawpixelimages |
Dreamstime Xxl 89801171
Photo courtesy of Luminex
Luminex Newborn Image

Recent MDx advances make congenital CMV testing more feasible

April 24, 2023
Human cytomegalovirus (CMV) could practically be a tale of two pathogens. Among healthy adults, CMV infections are quite common and largely asymptomatic. Indeed, by age 40, at...
Photo 104713915 © Kts |
Dreamstime Xxl 104713915

Liquid biopsies: Brilliant potential but highly workflow dependent

Since becoming commercially available over the last 10–15 years, liquid biopsies have been enthusiastically embraced, particularly for noninvasive prenatal screening and increasingly...
By S.Myshkovsky on Adobe Stock
Adobe Stock 465152235

BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test

Feb. 16, 2023
Single test on BD MAX Molecular Diagnostic System identifies and differentiates multiple respiratory infectious diseases.

Molecular diagnostics in treating lower respiratory tract infections with consideration for antimicrobial resistance

Nov. 22, 2022
Despite global focus on the COVID-19 pandemic, the concern around antimicrobial resistance (AMR) has continued to grow, albeit a bit further in the background. In 2019, AMR was...
By M.AKA on Adobe Stock
Adobe Stock 371025563

Roche introduces the cobas 5800

Nov. 2, 2022
A new molecular diagnostic system to expand access to PCR testing in the U.S.

State of the industry 2022: Molecular diagnostics

Oct. 19, 2022
The 2022 Medical Laboratory Observer (MLO) State of the Industry (SOI) survey on molecular diagnostics revealed some intriguing insights on the use of molecular testing by U.S...
Photo 80414627 © Alexey Novikov |
Dreamstime Xxl 80414627 (1)

Point-of-care (POC) molecular diagnostics global market report 2022

Aug. 31, 2022
Rising demand for point-of-care diagnostics augurs well for sector.
Courtesy of Cue Health
Test In Progress + Virtual Care

Independent study shows Cue Health’s molecular COVID-19 test accuracy compared to a lab-based PCR test

Aug. 22, 2022
In clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR.
Photo 170174524 © Borzywoj |
Dreamstime Xxl 170174524

Bringing down barriers to give better access to mass spectrometry in the clinical laboratory

July 20, 2022
Have you ever wanted to either implement or expand the use of liquid chromatography – tandem mass spectrometry (LC-MS/MS) in your clinical lab but have put off doing so because...
Pixabay Female Geddc4b298 1280

Study finds up to one-third of women receive misdiagnosis of vaginitis

Jan. 27, 2022
BD (Becton, Dickinson and Company) announced the outcome of a peer-reviewed study published in Obstetrics & Gynecology, showing that molecular diagnostics could improve the accuracy...